Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Witzig

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Investigation|July 3, 2025
Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphomaJithma P Abeykoon, Shuhei Asada, Guangli Zhu, et al.
Blood Advances|July 11, 2024
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphomaThomas Witzig, Lubomir Sokol, Won Seog Kim, et al.
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Investigation|July 3, 2025
Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphomaJithma P Abeykoon, Shuhei Asada, Guangli Zhu, et al.
Blood Advances|July 11, 2024
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphomaThomas Witzig, Lubomir Sokol, Won Seog Kim, et al.
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Pageof 4